SODIUM CHLORIDE 23.4% IN PLASTIC CONTAINER Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Sodium Chloride 23.4% In Plastic Container, and what generic alternatives are available?
Sodium Chloride 23.4% In Plastic Container is a drug marketed by Abraxis Pharm and is included in one NDA.
The generic ingredient in SODIUM CHLORIDE 23.4% IN PLASTIC CONTAINER is sodium chloride. There are one thousand four hundred and seventy-two drug master file entries for this compound. Twenty-four suppliers are listed for this compound. Additional details are available on the sodium chloride profile page.
Summary for SODIUM CHLORIDE 23.4% IN PLASTIC CONTAINER
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 142 |
Formulation / Manufacturing: | see details |
DailyMed Link: | SODIUM CHLORIDE 23.4% IN PLASTIC CONTAINER at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for SODIUM CHLORIDE 23.4% IN PLASTIC CONTAINER
US Patents and Regulatory Information for SODIUM CHLORIDE 23.4% IN PLASTIC CONTAINER
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Abraxis Pharm | SODIUM CHLORIDE 23.4% IN PLASTIC CONTAINER | sodium chloride | INJECTABLE;INJECTION | 019329-001 | Apr 22, 1987 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |